Srinivas Ghatta, Ph.D has over 22 years of Industrial experience in pharmaceutical sciences research and development. Dr. Ghatta received his first M.S. in Pharmacology and Toxicology at National Institute of Pharmaceutical Research (NIPER) in India and second was from Drexel University in Clinical Research Organization and Management. Dr. Ghatta completed his Ph.D. at North Dakota State University in Pharmaceutical Sciences. He was awarded a predoctoral fellowship from American Heart Association. Dr. Ghatta’s research has resulted in over 15 scientific publications. During his tenure with GSK and Genmab, Dr. Ghatta was part of Clinical development teams of three approved drugs: Dolutegravir, mepolizumab and Tisotumab vedotin.